![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, April 04, 2020 5:31:43 PM
While I agree with what you're saying, if we can prove that PLX-PAD works now, while I'd love to see it save a lot of lives, that can only happen if it becomes available in a matter of weeks. Until a vaccine that's effective is developed this will still be a big problem. If it's validated now, in the roughly November time frame where it may start to reappear, perhaps we can greatly limit it's impact by making it generally available for pneumonia patients.
Frankly, I believe pneumonia could be a far greater market than any of the other diseases they've targeted to date. I believe that all forms of pneumonia may benefit from our drugs, not just coronavirus based. Someone with medical knowledge believe that just two doses would be all that would be required. No doubt this won't be cheap, but it will be far cheaper then treating CLI or other diseases that take multiple applications in many places.
Gary
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM